| Primary |
| Hormone Replacement Therapy |
63.6% |
| Menopause |
6.5% |
| Depression |
3.9% |
| Off Label Use |
3.9% |
| Cardiac Disorder |
2.6% |
| Diabetes Mellitus |
2.6% |
| Hypersensitivity |
2.6% |
| Hypertension |
2.6% |
| Menopausal Symptoms |
2.6% |
| Oestrogen Replacement Therapy |
2.6% |
| Osteoporosis |
2.6% |
| Arthritis |
1.3% |
| Heart Rate Increased |
1.3% |
| Menstrual Disorder |
1.3% |
|
| Breast Cancer |
40.0% |
| Breast Cancer Female |
21.8% |
| Cerebrovascular Accident |
3.6% |
| Hypersensitivity |
3.6% |
| Metrorrhagia |
3.6% |
| Weight Decreased |
3.6% |
| Breast Cancer Metastatic |
1.8% |
| Breast Cancer Recurrent |
1.8% |
| Crying |
1.8% |
| Diabetes Mellitus |
1.8% |
| Drug Hypersensitivity |
1.8% |
| Fluid Retention |
1.8% |
| Hyperhidrosis |
1.8% |
| Nausea |
1.8% |
| Renal Cancer |
1.8% |
| Tumour Necrosis |
1.8% |
| Uterine Cyst |
1.8% |
| Vision Blurred |
1.8% |
| Vomiting |
1.8% |
|
| Secondary |
| Hormone Replacement Therapy |
88.0% |
| Menopausal Symptoms |
3.0% |
| Menopause |
2.2% |
| Hormone Therapy |
1.2% |
| Hypertension |
1.1% |
| Hot Flush |
0.5% |
| Hypothyroidism |
0.5% |
| Off Label Use |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Diabetes Mellitus |
0.3% |
| Drug Use For Unknown Indication |
0.3% |
| Oestrogen Replacement Therapy |
0.3% |
| Postmenopausal Haemorrhage |
0.3% |
| Depression |
0.2% |
| Hysterectomy |
0.2% |
| Libido Decreased |
0.2% |
| Oophorectomy |
0.2% |
| Sleep Disorder |
0.2% |
| Cardiac Disorder |
0.2% |
| Type 2 Diabetes Mellitus |
0.2% |
|
| Breast Cancer Female |
59.6% |
| Breast Cancer |
24.4% |
| Breast Cancer Metastatic |
4.8% |
| Progesterone Receptor Assay Positive |
2.1% |
| Ovarian Cancer |
1.5% |
| Breast Cancer In Situ |
0.9% |
| Abdominal Pain Lower |
0.6% |
| Deep Vein Thrombosis |
0.6% |
| Drug Ineffective For Unapproved Indication |
0.6% |
| Oestrogen Receptor Assay Positive |
0.6% |
| Pruritus |
0.6% |
| Stress |
0.6% |
| Vulvovaginal Dryness |
0.6% |
| Weight Decreased |
0.6% |
| Abnormal Behaviour |
0.3% |
| Anaemia |
0.3% |
| Bone Pain |
0.3% |
| Breast Cyst |
0.3% |
| Breast Discomfort |
0.3% |
| Cholecystitis Chronic |
0.3% |
|
| Concomitant |
| Osteoporosis |
20.0% |
| Contraception |
12.0% |
| Metastases To Bone |
12.0% |
| Anxiety |
8.0% |
| Flatulence |
4.0% |
| Growth Hormone Deficiency |
4.0% |
| Menopause |
4.0% |
| Multiple Sclerosis |
4.0% |
| Neuralgia |
4.0% |
| Premedication |
4.0% |
| Product Used For Unknown Indication |
4.0% |
| Sjogren's Syndrome |
4.0% |
| Bipolar Disorder |
2.0% |
| Depression |
2.0% |
| Dyspepsia |
2.0% |
| Fibromyalgia |
2.0% |
| Hypertension |
2.0% |
| Insomnia |
2.0% |
| Multiple Myeloma |
2.0% |
| Nasopharyngitis |
2.0% |
|
| Pain |
12.0% |
| Nasal Congestion |
8.0% |
| Rhinorrhoea |
8.0% |
| Sjogren's Syndrome |
8.0% |
| Vaginal Haemorrhage |
8.0% |
| Weight Decreased |
8.0% |
| Arthralgia |
4.0% |
| Carcinoma In Situ |
4.0% |
| Confusional State |
4.0% |
| Dystonia |
4.0% |
| Hyperglycaemia |
4.0% |
| Impaired Gastric Emptying |
4.0% |
| Injection Site Erythema |
4.0% |
| Lung Neoplasm |
4.0% |
| Mass |
4.0% |
| Neck Pain |
4.0% |
| Thyroid Function Test Abnormal |
4.0% |
| Urticaria |
4.0% |
|
